Not available
Quote | Microbot Medical Inc. (NASDAQ:MBOT)
Last: | $0.9401 |
---|---|
Change Percent: | -0.26% |
Open: | $0.97 |
Close: | $0.9401 |
High: | $0.97 |
Low: | $0.9396 |
Volume: | 48,178 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Microbot Medical Inc. (NASDAQ:MBOT)
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
BRAINTREE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today reports that the first phase of the previously announced collaboration with Corewell Health has been completed, which de...
Message Board Posts | Microbot Medical Inc. (NASDAQ:MBOT)
Subject | By | Source | When |
---|---|---|---|
Hmmmm not for me right now | Triple nickle | investorshub | 05/22/2023 1:30:41 PM |
$MBOT Microbot Medical Inc | subslover | investorshub | 05/22/2023 1:29:02 PM |
The trading | run256 | investorshub | 05/19/2023 2:33:45 AM |
$MBOT what do you make of this data? | run256 | investorshub | 05/19/2023 12:17:07 AM |
$MBOT got some short data | run256 | investorshub | 05/18/2023 1:08:14 AM |
News, Short Squeeze, Breakout and More Instantly...
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
BRAINTREE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today reports that the first phase of the previously announced collaboration with Corewell Health has been completed, which de...
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company Believes that Both Regulatory and Commercial Milestones to be Achieved in Accordance with the Company’s Current Timeline BRAINTREE,...